GOOD NEWS丨Congratulations on the approval of Lidocaine Hydrochloride Gel

On November 28, 2023, our cooperative client Beijing Mingzezhonghe Pharmaceutical Research Co., Ltd. (hereinafter referred to as "Mingzezhonghe") received the approval document from the National Medical Products Administration (NMPA), and the Lidocaine Hydrochloride Gel applied by Mingzezhonghe was approved for marketing. Our warm congratulations to Mingzezhonghe!

Lidocaine Hydrochloric Gel is an amide local anesthesia drug used for local surface anesthesia. The original research has not yet been listed in China and is a class 3 generic drug. Mingzezhonghe worked for years and was finally approved for sale. In the process of NDA application of the product, Yeedo guided the client to carry out reasonable and perfect supplementary research according to the registration regulations and technical evaluation requirements, and assisted the project successfully obtain the marketing approval.